Psychiatry & Neurology, Clinical Neurophysiology · Lexington, KY
NPI
1891037230
Since 2013
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
740 S Limestone Ky Clinic J401
Lexington, KY, 40536
Phone (859) 323-5661
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
191 services
Medicare patients, 2024
112
Average age 65
Drug cost, 2024
$1.2M
568 prescriptions
Company payments, 2025
$112
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ima M Ebong was code 95816 (neurologic), 40 times for 39 patients. In total Ima M Ebong billed 191 services in 24 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95816 Neurologic | Facility | 40 | 39 | $40.45 | $1,618 |
| 95720 Neurologic | Facility | 28 | 13 | $163.79 | $4,586 |
| 99215 Office E&M - Established | Facility | 22 | 20 | $105.69 | $2,325 |
| 99214 Office E&M - Established | Facility | 14 | 13 | $62.37 | $873 |
By year: 2022 $18K for 216 services; 2023 $10K for 120 services; 2024 $14K for 191 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ima M Ebong prescribed most often to Medicare patients was Levetiracetam, with 55 prescriptions and refills. In total Ima M Ebong wrote 568 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 55 | 92 | 13 | $1,773 |
| Lamotrigine Generic | 54 | 62 | Under 11 | $426 |
| Gabapentin Generic | 40 | 42 | Under 11 | $446 |
| Phenobarbital Generic | 35 | 35 | Under 11 | $875 |
| Lumizyme Alglucosidase Alfa | 26 | 26 | Under 11 | $723K |
| Topiramate Generic | 24 | 44 | Under 11 | $228 |
| Vyvgart Efgartigimod Alfa-Fcab | 23 | 23 | Under 11 | $364K |
| Mycophenolate Mofetil Generic | 22 | 50 | Under 11 | $1,469 |
| Oxcarbazepine Generic | 20 | 26 | Under 11 | $1,505 |
| Fycompa Perampanel | 19 | 19 | Under 11 | $21K |
| Clonazepam Generic | 17 | 17 | Under 11 | $374 |
| Briviact Brivaracetam | 17 | 17 | Under 11 | $23K |
| Clobazam Generic | 16 | 16 | Under 11 | $1,022 |
| Pyridostigmine Bromide Generic | 15 | 21 | Under 11 | $727 |
| Aptiom Eslicarbazepine Acetate | 13 | 13 | Under 11 | $20K |
Brand drugs: 147 claims; generic drugs: 386 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ima M Ebong $112 ($112 in general payments such as food, travel and fees) from 2 companies. The largest payer was SPR Therapeutics, Inc with $66.18.
| Company | Payments | Amount |
|---|---|---|
| SPR Therapeutics, Inc | 1 | $66.18 |
| UCB, Inc. UCB.BR | 1 | $45.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.